Expleo Solutions Limited

NSEI:EXPLEOSOL Stock Report

Market Cap: ₹22.5b

Expleo Solutions Past Earnings Performance

Past criteria checks 2/6

Expleo Solutions has been growing earnings at an average annual rate of 24.8%, while the IT industry saw earnings growing at 25.2% annually. Revenues have been growing at an average rate of 31.9% per year. Expleo Solutions's return on equity is 16.3%, and it has net margins of 10.7%.

Key information

24.8%

Earnings growth rate

14.7%

EPS growth rate

IT Industry Growth24.3%
Revenue growth rate31.9%
Return on equity16.3%
Net Margin10.7%
Next Earnings Update14 Feb 2025

Recent past performance updates

Expleo Solutions' (NSE:EXPLEOSOL) Conservative Accounting Might Explain Soft Earnings

Nov 22
Expleo Solutions' (NSE:EXPLEOSOL) Conservative Accounting Might Explain Soft Earnings

Recent updates

Further Upside For Expleo Solutions Limited (NSE:EXPLEOSOL) Shares Could Introduce Price Risks After 25% Bounce

Dec 18
Further Upside For Expleo Solutions Limited (NSE:EXPLEOSOL) Shares Could Introduce Price Risks After 25% Bounce

Expleo Solutions' (NSE:EXPLEOSOL) Conservative Accounting Might Explain Soft Earnings

Nov 22
Expleo Solutions' (NSE:EXPLEOSOL) Conservative Accounting Might Explain Soft Earnings

Expleo Solutions Limited's (NSE:EXPLEOSOL) CEO Compensation Is Looking A Bit Stretched At The Moment

Aug 24
Expleo Solutions Limited's (NSE:EXPLEOSOL) CEO Compensation Is Looking A Bit Stretched At The Moment

When Should You Buy Expleo Solutions Limited (NSE:EXPLEOSOL)?

Jun 21
When Should You Buy Expleo Solutions Limited (NSE:EXPLEOSOL)?

Investors Could Be Concerned With Expleo Solutions' (NSE:EXPLEOSOL) Returns On Capital

Mar 15
Investors Could Be Concerned With Expleo Solutions' (NSE:EXPLEOSOL) Returns On Capital

The Returns On Capital At Expleo Solutions (NSE:EXPLEOSOL) Don't Inspire Confidence

Sep 15
The Returns On Capital At Expleo Solutions (NSE:EXPLEOSOL) Don't Inspire Confidence

Increases to Expleo Solutions Limited's (NSE:EXPLEOSOL) CEO Compensation Might Cool off for now

Aug 19
Increases to Expleo Solutions Limited's (NSE:EXPLEOSOL) CEO Compensation Might Cool off for now

Calculating The Fair Value Of Expleo Solutions Limited (NSE:EXPLEOSOL)

Jul 14
Calculating The Fair Value Of Expleo Solutions Limited (NSE:EXPLEOSOL)

Many Would Be Envious Of Expleo Solutions' (NSE:EXPLEOSOL) Excellent Returns On Capital

May 05
Many Would Be Envious Of Expleo Solutions' (NSE:EXPLEOSOL) Excellent Returns On Capital

A Look At The Fair Value Of Expleo Solutions Limited (NSE:EXPLEOSOL)

Mar 15
A Look At The Fair Value Of Expleo Solutions Limited (NSE:EXPLEOSOL)

Expleo Solutions Limited's (NSE:EXPLEOSOL) Stock Been Rising: Are Strong Financials Guiding The Market?

Feb 15
Expleo Solutions Limited's (NSE:EXPLEOSOL) Stock Been Rising: Are Strong Financials Guiding The Market?

Expleo Solutions (NSE:EXPLEOSOL) Knows How to Allocate Capital

Jan 24
Expleo Solutions (NSE:EXPLEOSOL) Knows How to Allocate Capital

Introducing Expleo Solutions (NSE:EXPLEOSOL), A Stock That Climbed 76% In The Last Year

Jan 04
Introducing Expleo Solutions (NSE:EXPLEOSOL), A Stock That Climbed 76% In The Last Year

A Look At The Intrinsic Value Of Expleo Solutions Limited (NSE:EXPLEOSOL)

Dec 14
A Look At The Intrinsic Value Of Expleo Solutions Limited (NSE:EXPLEOSOL)

Is There More To The Story Than Expleo Solutions's (NSE:EXPLEOSOL) Earnings Growth?

Nov 26
Is There More To The Story Than Expleo Solutions's (NSE:EXPLEOSOL) Earnings Growth?

Revenue & Expenses Breakdown

How Expleo Solutions makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NSEI:EXPLEOSOL Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2410,1711,091230
30 Jun 249,91994200
31 Mar 249,649904230
31 Dec 239,4051,038160
30 Sep 239,3051,251160
30 Jun 239,1521,311160
31 Mar 239,0331,339160
31 Dec 225,07282360
30 Sep 224,77964860
30 Jun 224,43958360
31 Mar 227,42567790
31 Dec 213,70346340
30 Sep 213,36647540
30 Jun 213,13149040
31 Mar 213,00950440
31 Dec 202,97153440
30 Sep 202,93151240
30 Jun 202,85247540
31 Mar 202,70239940
31 Dec 192,627353280
30 Sep 192,614298280
30 Jun 192,741345280
31 Mar 192,865362280
31 Dec 182,973372270
30 Sep 182,949377270
30 Jun 182,898313270
31 Mar 182,764320270
31 Dec 172,5832565730
30 Sep 172,4882435730
30 Jun 172,4752305730
31 Mar 172,599238290
31 Dec 162,7472934020
30 Sep 162,8093294020
30 Jun 162,7903724020
31 Mar 162,6423694020
31 Dec 152,4452792900
30 Sep 152,3122712900
30 Jun 152,2122402900
31 Mar 152,1422163910
31 Dec 142,1162223010
30 Sep 142,0872263010
30 Jun 142,0272613010
31 Mar 141,9443003010
31 Dec 131,8193003050

Quality Earnings: EXPLEOSOL has high quality earnings.

Growing Profit Margin: EXPLEOSOL's current net profit margins (10.7%) are lower than last year (13.4%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: EXPLEOSOL's earnings have grown significantly by 24.8% per year over the past 5 years.

Accelerating Growth: EXPLEOSOL's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: EXPLEOSOL had negative earnings growth (-12.8%) over the past year, making it difficult to compare to the IT industry average (14.6%).


Return on Equity

High ROE: EXPLEOSOL's Return on Equity (16.3%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 03:42
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Expleo Solutions Limited is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anil BurraFirstCall Research
Naveed MD.FirstCall Research
Abhay MogheIL&FS Broking Services Private Limited